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Edited by Pe´ter FriedrichAbstract Programmed neuronal cell death is required during
development to achieve the accurate wiring of the nervous sys-
tem. However, genetic or accidental factors can lead to the pre-
mature, non-programmed death of neurons during adult life.
Inappropriate death of cells in the nervous system is the cause
of multiple neurodegenerative disorders. Pathological neuronal
death can occur by apoptosis, by necrosis or by a combination
of both. Necrotic cell death underlies the pathology of devastat-
ing neurological diseases such as neurodegenerative disorders,
stroke or trauma. However, little is known about the molecular
mechanisms that bring about necrotic cell death. Proteases play
crucial roles in neuron degeneration by exerting both regulatory
and catabolic functions. Elevated intracellular calcium is the
most ubiquitous feature of neuronal death with the concomitant
activation of cysteine calcium-dependent proteases, calpains.
Calpains and lysosomal, catabolic aspartyl proteases, play key
roles in the necrotic death of neurons. In this review, we survey
the recent literature on the role of cysteine and aspartyl prote-
ases in necrosis and neurodegeneration, aiming to delineate com-
mon proteolytic mechanisms mediating cellular destruction.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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It is becoming increasingly clear that multiple mechanisms
of cell death, as well as a crosstalk between diﬀerent death
pathways, contribute to neurodegeneration. Speciﬁc mecha-
nisms dictate cell death in particular neurodegenerative dis-
eases depending on the nature and severity of the insult to
the cell, as well as on the cellular context [1,2]. Moreover, dif-
ferent death mechanisms may operate in diﬀerent parts of the
same stressed neuron [3,4]. Acute and chronic neurodegenera-
tive conditions have been associated with both, apoptotic and
necrotic cell death [5–8]. While necrosis and apoptosis can be
distinguished in some situations, in others the distinction is
not so clear [3] and certain dying cells might show distinctive
features of both apoptosis and necrosis [9,10]. The idea of a
continuum of responses ranging from apoptosis to necrosis is*Corresponding author. Fax: +30 2810 391067.
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doi:10.1016/j.febslet.2005.03.052emerging, where the relative contributions of each depends
on several factors, including the energy content of the cell
and the severity of the insult [3]. Neurons at the core of an
ischemic lesion undergo necrotic death and are resistant to cas-
pase inhibitors, whereas neurons at the periphery show apop-
totic features and can be partially rescued by caspase inhibitors
[11].
Apoptosis is a genetically regulated process of cell-suicide
that is modulated by a variety of cellular signalling pathways
that integrate common death eﬀectors with a range of diﬀerent
stimuli [12]. The morphologic features of apoptosis include nu-
clear and cytoplasmic condensation, internucleosomal DNA
cleavage and packaging of the cell into apoptotic bodies that
are engulfed by phagocytes, preventing release of intracellular
components [13]. Two main pathways lead to apoptotic neuro-
nal cell death. (1) Mitochondrial damage, due to reactive oxy-
gen species (ROS), increased Ca2+ inﬂux, hypoxia, UV, etc.
leads to cytochrome c release into the cytosol, with the subse-
quent formation of the apoptosome and the activation of eﬀec-
tor caspases (caspase-3, -7). This is frequently referred to as the
intrinsic pathway. (2) The extrinsic pathway, where binding
of ligands to death receptors of the tumour necrosis factor
family induces the activation of eﬀector caspases through the
c-Jun-N-terminal kinase. Activation of caspase-8 [14] results
in cleavage of BID and cytochrome c release [15]. Caspase-8
activation can also directly stimulate eﬀector caspases [16].
Although mediated by diverse mechanisms, apoptosis always
requires the proteolytic activation of eﬀector caspases (cas-
pase-3 and caspase-7), caspase-3 being a key molecule [17].
Canonical caspase-dependent neuronal apoptosis shapes the
nervous system during development. However, things get more
complicated for neuronal death during adulthood [2]. Neurons
often show caspase-independent apoptotic features and in
some cases, co-activation of several parallel death pathways
is required before cell death can take place [18,19]. Other than
caspases, calpains and cathepsins have also been implicated in
apoptotic neuronal death (see below).
Contrary to apoptosis, necrosis is not a developmentally
programmed type of cell death. Instead, necrotic cell death oc-
curs by deregulation of normal cellular activities when cells are
exposed to extreme stress conditions. Necrosis is morphologi-
cally characterised by extensive vacuolation of the cytoplasm,
mitochondrial swelling, dilatation of the endoplasmic reticu-
lum and plasma membrane rupture. The cell is lysed without
formation of vesicles. As a consequence, cellular contents are
liberated into the intracellular space, which might precipitate
damage to neighbouring cells and evoke inﬂammatoryblished by Elsevier B.V. All rights reserved.
3288 M. Artal-Sanz, N. Tavernarakis / FEBS Letters 579 (2005) 3287–3296responses [20]. Necrosis typically occurs following ischaemia,
hypoxia, stroke or trauma [21] but it has also been reported
in Alzheimers disease (AD), Huntingtons disease (HD), Par-
kinsons disease (PD), and amyotrophic lateral sclerosis
(ALS) [4,22–25]. Although the molecular mechanisms that
bring about necrotic cell death are not fully elucidated, exper-
imental evidence indicates that necrosis of adult neurons is
mediated by increase of intracellular Ca2+, is independent of
caspases, and instead, cytosolic calpains and spilled lysosomal
cathepsins are the major players in necrotic neuronal death
(see below).
Energy depletion is a potent trigger of necrosis. During
ischemic and hypoglycaemic episodes, lack of oxygen or essen-
tial nutrients leads to a shortage of energy to sustain the mem-
brane potential. As a consequence, plasma membrane
depolarization occurs, which results in massive release of the
excitatory neurotransmitter glutamate at synaptic clefts. Over-
stimulation of the glutamate N-methyl-D-aspartate (NMDA)
receptor and the a-amino-3-hydroxy-5-methyl-4-isoxazole pro-
pionic acid (AMPA) receptor channel leads to Ca2+ and Na+
overload in postsynaptic neurons [26] (Fig. 1). Additionally,
the secondary activation of voltage-gated calcium channels
[27] also contributes to Ca2+ overload and ultimately, the ne-
crotic death of postsynaptic neurons. This phenomenon is
known as excitotoxicity in mammals and primarily involves
the elevation of intraneuronal calcium concentration. Excito-
toxicity is not only related to acute neurodegenerative condi-
tions such as ischaemia/anoxia, epilepsy, brain trauma orFig. 1. The central role of calcium in neurodegeneration. Some of the
neurodegeneration are depicted. Gating of AMPA, NMDA, ASIC and TRPM
inside the cell. The sharp increase of intracellular calcium concentration is
resulting in the subsequent activation of calpains. Activated calpains cleave
NCX, which is involved in calcium extrusion, becomes inactivated. Both
Depending on the level of calpain activation, neurons might undergo apo
underlying neuronal death showing predominantly apoptotic features. The d
ﬁndings in nematode and primate neurons undergoing necrotic cell death [88
occur independently of calpains. Dashed arrows point to identiﬁed protease ta
5-methyl-4-isoxazole propionic acid; NMDA, N-methyl-D-aspartate; ASIC,
channel and NXC, Na+/Ca2+ exchanger.spinal cord injury (SCI), but also to chronic neurodegenerative
conditions such us AD [28–30]. Apart from excitotoxicity,
other neurotoxic processes involved in neuronal death have re-
cently been unravelled in mammalian systems. Using cultured
murine cortical neurons subjected to oxygen/glucose depriva-
tion as a model of hypoxia, Aarts et al. [31] discovered a
new lethal pathway involving a Ca2+-permeable non-selective
cation conductance. The authors observed that this cation con-
ductance results in Ca2+ overload and requires the TRPM7 ion
channel. TRPM7 is activated by reactive oxygen/nitrogen spe-
cies and allows Ca2+ entry into the neuron. Ca2+ overload fur-
ther stimulates free radical production and additional Ca2+
entry through this channel despite blockade of NMDA recep-
tors. Suppression of TRPM7 conductance prevented neuronal
death both in the presence and in the absence of NMDA
blockade (Fig. 1). Acidiﬁcation, which is a consequence of oxy-
gen depletion, also plays an important role in necrotic neuro-
nal death [32]. A recent report shows that acidosis activates
Ca2+-permeable acid sensing ion channels (ASICs) resulting
in glutamate receptor-independent neuronal injury due to
Ca2+ toxicity [33] (Fig. 1). Injection of ASIC1a blockers or
knockout of the ASIC1a gene protects the brain from ischemic
injury more potently that glutamate antagonism [33].
In Caenorhabditis elegans, altered ion homeostasis results in
the necrotic death of speciﬁc neurons. Necrotic cell death can
be triggered by toxic mutations in several genes. The best char-
acterize case involves gain-of-function mutations in genes
encoding the ion channel proteins termed degenerins [34,35].membrane receptor channels involved in necrotic cell death and
7 channels in postsynaptic neurons provokes an inﬂux of calcium ions
the principal death-signalling event in both necrosis and apoptosis,
NMDA [86] and NCX channels [87]. NMDA remains active, whereas
these events contribute to further elevation of intracellular calcium.
ptotic or necrotic death. The left side of the ﬁgure illustrates events
irect link between calpains and cathepsins (right side) is supported by
,128]. However, lysosomal damage and activation of cathepsins might
rgets (see text for details). Abbreviations: AMPA, a-amino-3-hydroxy-
acid sensing ion channel; TRPM7, transient receptor potential cation
Fig. 2. Neurodegenerative disease in Caenorhabditis elegans. A nem-
atode neuron undergoing necrosis as a result of degenerin ion channel
hyperactivation. The degenerating cell swells to several times its
normal diameter, whereas the nucleus is distended and has a distorted
morphology. Black arrow points to the degenerating neuron.
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cell death with morphologic and mechanistic features of
mammalian excitotoxic cell death [36] (Fig. 2). Degenerins
share similarity with mammalian epithelial sodium channels
(ENaCs) [37]. In addition to degenerins, mutations that hyper-
activate the a-subunit of the nicotinic acetylcholine receptor
(nAChR) [38], or constitutively activate G-protein a-subunit
[39,40] also result in alterations of cellular ionic homeostasis
and induce necrotic cell death in C. elegans. Recent studies
demonstrate that Ca2+ is also a central eﬀector of C. elegans
neurodegeneration, since proteins of the endoplasmic reticu-
lum that regulate intra-cellular Ca2+ levels are required for ne-
crotic cell death. These include the calcium-binding chaperones
calreticulin and calnexin, and the calcium channels InsP3R
and RyR [41].
Elevated intracellular Ca2+ is the most ubiquitous feature of
neuronal death, which can result in both apoptotic- and necro-
tic-like type of cell death. The contribution of each type of cell
death appears to correlate with the severity of the insult [42].
Calcium overload triggers lethal downstream events, including
oxidative stress, mitochondrial dysfunction and calcium-
dependent protease activation. Proteases can be considered
as the executioners of cell death, and when a lethal protease-
cascade is set in motion, cell demise becomes inevitable. In
the following section we review the current state of our under-
standing about the proteolytic mechanisms involved in necro-
tic cell death and neurodegeneration.Table 1
Protease classes implicated in neurodegeneration
Protease family Activation mechanism
Caspase Proteolytic processing;







Proteolytic processing by other lysosomal enzyme
Abbreviations: PM, plasma membrane; APP, amyloid-b precursor protein.2. Proteases in neurodegeneration and necrosis
A wide variety of proteases are engaged in cell death pro-
cesses through both non-speciﬁc and limited proteolysis. These
include cytosolic cysteine and aspartyl proteases, lysosomal
proteases, microglial proteases [43] and the ubiquitin protea-
some system [44]. In this section, we mainly focus on cytosolic
cysteine-proteases (caspases and calpains) and lysosomal
aspartyl-proteases (cathepsins) involved in necrotic cell death
and neurodegeneration.
2.1. Caspases
Caspases are the main executioners of apoptotic cell death.
Caspases constitute a family of cysteine proteases which specif-
ically cleave after an aspartic residue in target proteins. Apop-
totic caspases are classiﬁed as initiator caspases (caspase-2, -8,
-9, and -10) and eﬀector or executioner caspases, which include
caspase-3, -6, and -7. Caspases are produced as inactive zymo-
gens and must undergo activation during apoptosis. The acti-
vation of eﬀector caspases is performed by an activated
initiator caspase, through cleavage at speciﬁc internal Asp res-
idues. The activation mechanism of initiator caspases is auto-
catalytic. Whether this requires cleavage or just dimerization is
still under debate [45]. Activation of an initiator caspase trig-
gers the apoptotic caspase-cascade and it is, therefore, tightly
regulated and often requires the assembly of a multicomponent
complex such as the apoptosome, where caspase-9 binds to
mitochondrially released cytochrome c and APAF1 to form
a 1.4 MDa complex. Activation of caspases requires ATP.
Once activated, the executioner caspases are responsible for
the proteolytic cleavage of a broad spectrum of cellular targets
(see Table 1) leading ultimately to cell death. Among all casp-
ases caspase-3 is of particular interest because it appears to be
a common downstream eﬀector. Caspase-3 substrates include
cytoskeletal proteins such as spectrin, DNA-repairing en-
zymes, cell-cycle proteins and enzymes involved in signal
transduction.
Caspase-mediated proteolysis also appears to have a role in
necrosis. Caspases can activate calpain proteases by mediating
degradation of calpastatin, an endogenous inhibitor of cal-
pain [46] and caspases might become activated by calpain pro-Substrates Reference
Cytoskeletal proteins [120]






Signal transduction proteins [61,120]
Receptor ion channels [86,87]
Caspases [69,70]




s Proinﬂammatory caspases [98]
APP [106]
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drial damage and cytochrome c release, which might ulti-
mately lead to caspase activation [48]. Caspase-3 has been
demonstrated to be involved in neuronal death after transient
cerebral ischaemia [49] and the plasma-membrane Ca2+ pump
in neurons is a substrate for caspase-mediated cleavage and
inactivation [50]. In addition, caspases might contribute to
the neuronal death associated with the formation of intracel-
lular polypeptide aggregates by cleaving the amyloid-b
precursor protein (APP), presenilins, huntingtin (htt), tau
and a-synuclein [51], which in turn become more toxic after
cleavage.2.2. Calpains
Calpains are a family of calcium-dependent cysteine prote-
ases that perform limited proteolytic cleavage of a variety of
cellular substrates [52]. There are two ubiquitous isoforms of
calpains, l-calpain (calpain I) and m-calpain (calpain II) that
are activated by micro- and milli-molar concentrations of
Ca2+ in vitro, respectively. Tissue-speciﬁc isoforms sum up a
total of 14 members [53]. The ubiquitous isoforms are hetero-
dimers composed of a distinct 80 kDa catalytic subunit and an
identical 30 kDa regulatory subunit. Both, the large and the
small subunit contain multiple calcium-binding sites [54,55].
Deletion of the shared 30 kDa subunit in mice results in
embryonic lethality [56] whereas deletion of the 80 kDa sub-
unit of l-calpain does not precipitate any severe phenotype
[57], indicating that m-calpain plays an important role during
early development. Additional functions have been ascribed to
calpains in cell motility and growth cone motility and guidance
in neurons [58]. Mutations in Calpain III, a skeletal muscle-
speciﬁc calpain, result in a recessive form of limb-girdle muscu-
lar dystrophy [59].
The role of calpains in neuronal cell death has been exam-
ined in a number of neuropathological conditions [60–62].
Inhibition of calpains prevents neuronal and behavioural de-
fects in a mouse model of PD and calpain activation was evi-
dent in post-mortem midbrain tissues from cases of PD [63]. In
the case of AD, calpain activation can be detected before
abnormalities in the microtubule-associated protein tau occur.
Activated calpain associates with neuroﬁbrillary tangles, which
are abnormal aggregates of hyperphosphorylated tau and a
major pathological feature of AD [64]. Calpains also appear
to function as upstream activators of the ERK1,2 MAPK sig-
nalling pathway and mediate in part the hyperphosphorylation
of tau and neuroﬁlaments [65]. Calpains are also activated in
HD [66] and htt is degraded to small fragments by calpain after
ischemic injury in rat brains [67].
Calpain activation has also been reported in a number of in
vivo and cell culture models of apoptosis. Members of the Bcl-
2 protein family of cell death regulators can be processed by
calpains [68]. Calpain-mediated cleavage of caspases that can
result in both, caspase inhibition [69] and activation [70] has
also been reported. Conversely, caspases might regulate cal-
pain activity by mediating degradation of calpastatin, the
endogenous inhibitor of calpain. Calpains have also been
implicated in the activation of p53 [71]. The authors examined
the requirement of calpain activation in the death of cultured
cortical neurons evoked by DNA damage. Inhibition of cal-
pain by either association with its intrinsic inhibitor calpastatin
or by pharmacological inhibitors results in reduced p53 activa-tion and cytochrome c release, preventing death of embryonic
cortical neurons.
There is also evidence of caspase-independent contribution
of calpains to apoptotic events that accompany excitotoxicity
[72,73]. Calpain inhibition with leupeptin has been shown to
improve survival of primary rat motoneurons exposed to
AMPA-mediated excitotoxicity, as well as motoneuron sur-
vival and muscle function in 3-day-old rats following neonatal
nerve injury [74]. Recent in vitro experiments show that, in iso-
lated liver and brain mitochondria, release of the apoptosis
inducing factor (AIF) requires active calpain whereas release
of cytochrome c does not. Calpeptin-mediated inhibition of
calpain precludes AIF release [75]. AIF has been shown to play
a role in excitotoxicity initiated by NMDA receptors indepen-
dent of caspases [76] and has been found to translocate to the
nucleus prior to cytochrome c release from mitochondria [76–
78]. It remains to be determined whether AIF cleavage by cal-
pain plays a role in Ca2+-mediated excitotoxicity. Studies in
mutant mice lacking or overexpressing the endogenous calpain
inhibitor calpastatin suggest that calpain mediates excitotoxic
signals through mobilization of pro-apoptotic factors [79].
The authors report that modulation of calpastatin had no ef-
fect under normal conditions suggesting that calpastatin
inhibits calpains only under pathological conditions. After kai-
nite-evoked excitotoxicity at concentrations that mimic tran-
sient ischaemia associated with apoptotic features, the
authors observed activation of Bid, nuclear translocation of
mitochondrial AIF and EndoG, DNA fragmentation and nu-
clear condensation without evidence of caspase-3 activation
(Fig. 1). Those apoptotic features were enhanced in calpastatin
deﬁcient mice and suppressed in calpastatin overexpressing
mice. Moreover, comparison of transgenic mice overexpressing
calpastatin with mice overexpressing a viral inhibitor of casp-
ases after kainite-mediated excitotoxixity revealed a prominent
role for calpains in excitotoxic cell death. Hippocampal neu-
rons are rescued from neuritic cytoskeleton disruption in mice
overexpressing calpastatin, whereas caspase suppression had
no eﬀect on the neuritic pathologies [80]. The authors demon-
strate that kainite-evoked sub-acute neuronal death involves
calpain-mediated cytoskeletal disorganization independently
of DNA fragmentation and that caspases do not play major
roles in the disorganization of cytoskeletal networks. Addi-
tionally, the contribution of the caspase system appears negli-
gible in the adult brain as manifested by the apparent absence
of caspase-3.
The importance of calpain activation in acute cell injury and
necrotic cell death triggered by calcium inﬂux has been largely
established. One of the mechanisms by which calpain activa-
tion contributes to cell demise is the cleavage of several essen-
tial cytoskeletal proteins of neuronal axons, such us
neuroﬁlaments, cain/cabin 1 and fodrin. Oxygen/glucose depri-
vation during anoxia and ischaemia of isolated rat optic nerves
causes degradation of neuroﬁlaments. Degradation of neuroﬁl-
aments could be attenuated by Ca2+ removal, blockade of volt-
age-gated Na+ channels or inhibition of calpains [81]. Cain/
cabin 1 contains a calcineurin-binding domain at the C-termi-
nal region and calpain cleaves cain/cabin 1 in this region. It has
been suggested that calpain-mediated cleavage of cain/cabin 1
results in calcineurin activation, which mediates calcium-trig-
gered cell death [82]. Calpain-mediated proteolysis of fodrin
has also been observed during necrotic cell death induced by
hypoxia in rat cardiomyocytes [83]. Titin, the largest myoﬁla-
M. Artal-Sanz, N. Tavernarakis / FEBS Letters 579 (2005) 3287–3296 3291ment protein in vertebrate striated muscle, is also target of cal-
pain-mediated degradation in cardiomyocytes undergoing ne-
crotic cell death [84]. Myosin Va belongs to the class V
myosin proteins that move cargo along actin ﬁlaments and is
involved in vesicle transport. In cerebellar granule neurons,
myosin Va is cleaved by calpain I after exicitotoxicity. Calpain
inhibitors prevent myosin Va proteolysis and improve mor-
phological appearance of neurons, probably by preserving
the integrity of the cytoskeleton [85]. Another mechanism by
which calpain contributes to cell death is the cleavage of mem-
brane channels. Calpain has been shown to cleave the subunit
NR2B of the NMDA receptor under excitotoxic conditions in
vitro and in vivo [86] (Fig. 1). Cleaved NR2B remains on the
extracellular surface and it is predicted to be active. However,
the contribution of the cleaved form to excitotoxicity has not
been determined. A recent report provides insight into the
molecular mechanisms by which calpains contribute to excito-
toxic cell death. During excitotoxicity, Ca2+ inﬂux through
glutamate receptors is followed by a second, delayed, uncon-
trolled Ca2+ increase that leads to neuronal demise. Bano
et al. [87] show that the plasma membrane Na+/Ca2+ exchan-
ger (NCX) is cleaved by calpains during brain ischaemia in
neurons undergoing excitotoxicity. NCX operates in cellular
Ca2+ extrusion, and its proteolytic inactivation seems to be
responsible for the delayed excitotoxic Ca2+ upregulation
and the death of the neurons. Inhibition of calpains by overex-
pression of calpastatin, or an NCX isoform not cleaved by cal-
pains, prevents secondary Ca2+ overload and rescues neurons
from excitotoxic death (Fig. 1).
Genetic studies in C. elegans demonstrate the requirement
for calpain activation in the execution of neurodegenerative
cell death inﬂicted by various genetic lesions [88]. Suppression
of necrosis by systematic RNAi-mediated knock down of cal-
pains encoded in the nematode genome coupled with analysis
of double mutants showed that two speciﬁc calpain proteases
(CLP-1 and TRA-3) are mostly required for proper execution
of necrotic cell death (see Fig. 3).
2.3. Cathepsins
The lysosomal system plays a key role in cellular destruction
during cell death. Two classes of lysosomal proteolytic en-
zymes appear to be the most active in neurodegeneration –
aspartyl (cathepsin D) and cysteine (cathepsin B, H and L)
proteases. Cathepsin proteases are implicated in both intracel-
lular proteolysis and extracellular matrix remodelling and play
important roles in numerous cellular processes by exerting deg-
radation and regulatory functions. Lysosomal cathepsins play
a role in both apoptosis and necrosis [89]. In addition to lyso-Fig. 3. A proteolytic cascade mediating necrosis in Caenorhabditis
elegans. Execution of necrotic cell death in the nematode requires the
activity of both calpain and cathepsin proteases. Two speciﬁc calpain
proteases, TRA-3 and CLP-1, function redundantly upstream of
aspartyl proteases ASP-3 and ASP-4 to mediated necrotic death [88].
Such an arrangement is consistent with a function of calpains in the
activation of cathepsins, in accordance with the calpain–cathepsin
hypothesis [128].somal cathepsins, cathepsins released from microglial cells also
play an important role in neuronal death by degrading extra-
cellular matrix proteins [90]. Deregulation or absence of
cathepsins has important consequences on the maintenance
and function of the nervous system. Mice lacking cathepsins
B and L die during the second to fourth week of life and dis-
play neuronal loss and brain atrophy [91]. Cathepsin D deﬁ-
ciency induces a lysosomal storage disease associated with
ceroid lipofuscin in mouse CNS neurons, and degeneration
of neurons in the mouse retina [92]. Similarly, mutated cathep-
sin D causes lysosomal storage disease and profound neurode-
generation in mammals [93]. Leakage of cathepsins due to
damaged lysosomal membranes during ageing also contributes
to neuron degeneration. Cathepsins have also been directly
implicated in long term memory (LTM) formation. Mutations
in the cer gene, encoding an inhibitor of cathepsins in Drosoph-
ila melanogaster, result in LTM defects [94]. cer expression in-
creases after LTM conditioning, suggesting that cathepsins are
activated early in LTM formation.
Several studies report diﬀerential expression of lysosomal
cysteine proteases in models of neurological disorders. Lyso-
somal cathepsins B and L have been implicated in delayed neu-
ronal death after global and focal cerebral ischaemia.
Increased amount and activity of cathepsin B has been re-
ported in hippocampal neurons after global ischaemia, and
speciﬁc inhibitors of cathepsins B and L eﬀectively reduce
ischaemic cerebral damage [95]. Involvement of cathepsin B
in motor neuron degeneration in cases of ALS has also been
reported [96].The immunoreactivity of cathepsins H, L and
D was not signiﬁcantly diﬀerent between control and ALS
cases, whereas cathepsin B was downregulated. Cystatin C is
an endogenous inhibitor of lysosomal cysteine proteases. Lar-
ger brain infarcts were found in cystatin C knockout mice, fol-
lowing focal ischaemia. In contrast, brain damage after global
ischaemia was diminished in cystatin C knockout mice [97].
Cathepsin B release is an early event following occlusion of
cerebral arteries, which eventually triggers the activation of
pro-inﬂammatory caspases (caspase-1 and -11) in focal cere-
bral ischaemia [98]. In a cell culture model of sub-lethal
NMDA-induced injury, speciﬁc blockade of cathepsin B/L
type protease activity signiﬁcantly attenuated spine damage
[99]. Microglial-secreted cathepsin B has also been identiﬁed
as a mediator of neuronal death induced by the amyloid-b pep-
tide in vitro [100].
Cathepsin D is involved in neuronal death induced by age-
ing, transient forebrain ischaemia and excessive stimulation
of glutamate receptors during excitotoxicity [101]. Increased
cathepsin D expression has been observed in both neuronal
and glial cells of rat brain after treatment with kainate, partic-
ularly in regions that show features of neurodegeneration
[102]. Age-related changes in the subcellular localization of
cathepsin D in rat cerebral cortex indicate that leakage of
cathepsin D into the cytoplasm in old rats is closely associated
with neurodegeneration [103], while reduction of lysosomal
membrane stability and increased cytosolic cathepsin D is ob-
served in aged brain and in AD. Similarly, distribution of
cathepsin D-immunoreactive cell bodies in aged dogs resem-
bles that in AD, reﬂecting a conserved pattern of brain ageing
in mammals [104]. The implication of cathepsin D in AD has
also been established. Lysosome numbers and the concentra-
tion of cathepsin D increase in neurons that are vulnerable
to AD before the onset of pathology [101,105]. Cathepsin D
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the APP into b-amyloid [106]. Cathepsin D and B activity is
increased in familial early-onset AD (FAD) caused by muta-
tions in presenilin. Presenilin modulates proteolysis and turn-
over of several signalling molecules, and appears to have a
direct eﬀect on the lysosomal system [107]. Presenilin 1 (PS1)
interacts with telencephalin (TLN) and the APP via their
transmembrane domain. Cathepsin D deﬁciency results in
the localization of TLN to autophagic vacuoles, similarly to
what is observed in PS1 (/) neurons [108]. A mouse model
of Niemann-Pick type C disease shows a mild age-related in-
crease in cathepsin-D content within nerve cells in many brain
regions, with cathepsin-D elevation being greatest in microglial
cells [109]. Cathepsin D is also found in early endosomes of
cultured cortical neurons with Niemann-Pick type C defects
[110]. Cathepsin D is diﬀerentially expressed in macrophages
and microglia in a mouse model of SCI [111]. Cathepsin D is
also involved in HD. When truncated htt is expressed in vitro,
immunoreactive cytoplasmic bodies containing htt are formed
(htt bodies). The ﬁbrillar core of these htt bodies contains
cathepsin D [112].
The requirement of aspartyl proteases in necrotic cell
death and neurodegeneration has also been demonstrated in
C. elegans. Reduction of aspartyl protease activity by speciﬁc
mutations, chemicals or starvation protected against neurode-
generation inﬂicted by various insults, including hyperacti-
vated degenerins, the nAChR subunit, DEG-3 and the
G-protein subunit Gas [88]. While at least six aspartyl protease
genes (asp-1 to asp-6) are expressed in C. elegans [113], two
speciﬁc cathepsins, ASP-3 and ASP-4, appear to synergistically
mediate necrotic cell death. Moreover, overexpression of
ASP-3 and ASP-4 is suﬃcient to induce necrosis [88] (Fig. 3).3. Protease activation in neurodegeneration
What signals trigger protease mal-activation during patho-
logical cell death? Elevation of intracellular calcium concentra-
tion during the initial stages of cell death elicits activation of
calpain proteases. Since raise of intracellular calcium is the
most ubiquitous feature in neurodegeneration, calpain activa-
tion represents a critical step in both, apoptotic and necrotic
neuronal death (Fig. 1). Nonetheless, the physiological role of
calpains is not to contribute to the unwanted death of neurons.
Rather, upon activation, the precise and limited cleavage of key
structural and signalling proteins by calpains serves to modu-
late protein function. As discussed above, mouse m-calpain
plays an important role during early development [57], and cal-
pains have been ascribed functions in cell motility and guidance
[58,114]. Mutations in Drosophila calpain D results in a rudi-
mentary optic lobe and in altered ﬂying and walking behaviours
due to the absence of certain neurons [115]. Similarly, one of the
C. elegans calpains required for neurodegeneration (TRA-3) is
involved in sex determination [116]. However, inﬂux of Ca2+ to
the cytoplasm results in aberrant calpain activation and con-
comitant cellular degeneration. An increase in intracellular
Ca2+ may occur in response to diverse necrosis-initiating stim-
uli such as excess glutamate, acidosis [33] or reactive oxygen/
nitrogen species (ROS) [31]. It is conceivable that the degree
of Ca2+ elevation and ensuing calpain activation will determine
whether cells dye by apoptosis or necrosis. Mild Ca2+ elevation
favours apoptosis [117], whereas acute calpain activation pre-cipitates necrosis probably via catastrophic cleavage of regula-
tory and structural proteins [88].
Cathepsins play important roles during the development and
in the function of the nervous system through regulated intra-
cellular and extracellular proteolysis. However, the inappropri-
ate activation of cathepsins has devastating consequences on
cell viability. How are cathepsins mal-activated or mis-local-
ized during inappropriate cell death? Studies in primates indi-
cate that damage to the lysosomal membrane is inﬂicted
enzymatically by activated calpains (Fig. 1). Calpains localize
to lysosomal membranes after the onset of ischemic episodes
with subsequent spillage of cathepsins to the cytoplasm [118].
This observations lead to the formulation of the calpain–
cathepsin hypothesis, whereby Ca2+-mediated activation of
calpains results in rupture of lysosomes and leakage of killer
cathepsins that eventually dismantle the cell. In C. elegans,
two speciﬁc calpains, TRA-3 and CLP-1, have been shown
to function upstream of cathepsins ASP-3 and ASP-4 during
degeneration inﬂicted by various necrosis initiators [88] (Fig.
3). Permeabilization of lysosomal membranes has also been re-
ported in cases of apoptosis [20]. In a recent screen for drugs
that activate p53-independent apoptosis in colon cancer, sev-
eral compounds have been found to induce lysosomal mem-
brane permeabilization, mis-localization of cathepsins B and
D, and apoptotic cell death. However, at higher concentrations
many of these compounds induce loss of cell membrane integ-
rity, diminished caspase activity and reduced cell viability, sug-
gesting a shift from apoptosis to necrosis [119]. Although, a
further increase in cytosolic cathepsins at higher drug concen-
trations has not been reported, the results suggest that mild
leakage of cathepsins from lysosomes results in apoptosis,
while unrestrained leakage leads to catastrophic cellular
destruction and necrosis.
Nevertheless, the molecular pathways leading to the activa-
tion of the diﬀerent proteases involved in neurodegeneration
are certainly more complex due to crosstalk between proteo-
lytic mechanisms; cathepsins activate caspases [98], caspases
activate calpains [46], and vice versa [70]. Moreover, activating
pathways are likely to diﬀer depending on the neuronal popu-
lation and the nature or severity of the insult.4. Concluding remarks and future prospects
Enzymatic proteolysis is involved in diverse neuropathologi-
cal conditions including acute and chronic neurodegenerative
diseases. Several lines of investigation converge to implicate
caspases, calpains, cathepsins and other proteases in both,
apoptotic and necrotic neuronal death. However, the molecu-
lar mechanisms that govern the erroneous activation of prote-
ases in neurodegenerative processes as well as the downstream
cascades that are set in motion remain largely elusive. Several
diﬃculties have hampered progress towards elucidation of the
proteolytic pathways involved in neurodegeneration. Among
them is the fact that caspases and calpains cleave many com-
mon substrates including cytoskeletal and regulatory proteins
[46,120] (see Table 1), and also the extensive crosstalk between
diﬀerent proteolytic systems [117]. The capacity of proteases to
modulate signal transduction pathways [61] further compli-
cates the delineation of their precise roles in vivo due to pleo-
tropic eﬀects. Another important issue is that synthetic
protease inhibitors initially thought to be speciﬁc for a given
M. Artal-Sanz, N. Tavernarakis / FEBS Letters 579 (2005) 3287–3296 3293protease class were subsequently found to have a broader inhi-
bition range. For example, calpain-speciﬁc synthetic inhibitors
also act on other cysteine proteases, such as cathepsin B [121]
and several caspase inhibitors including Z-VAD-fmk and Z-
DEVD-fmk have been shown to directly block calpain activity
and necrotic cell death after traumatic brain injury [122,123].
Therefore one should be cautious when drawing conclusions
based on experiments with synthetic inhibitors.
Disruption of calcium homeostasis plays a key role in neuro-
nal injury. Elucidating the function of calpains, which are
tightly regulated by intracellular calcium, is of great impor-
tance. The recent generation of genetically engineered mice
overexpressing the endogenous calpain inhibitor calpastatin
[80], as well as the progress in imaging calpain protease activity
in living mice [124] will certainly contribute to enhance our
understanding of the speciﬁc roles of calpain proteases in dif-
ferent neurodegenerative processes in vivo.
As discussed above, disturbance of cathepsin enzymatic activ-
ities accompanies brain ageing and neurodegeneration. Apart
from leakage of lysosomal cathepsins due to rupture of lyso-
somal membranes or to aberrant calpain activation, microglial
cathepsins also contribute to neurodegeneration [90]. In addi-
tion, it is worthmentioning that lysosomal cathepsins have been
found to undergo alternative traﬃcking routes. An alternatively
spliced form of cathepsin B localizes to mitochondria and pro-
vokes cell death [125], whereas another cysteine protease,
cathepsinsL, derived from translation ititiation at adownstream
AUG site and devoid of a signal peptide, is targeted to the nu-
cleus [126]. This suggests additional pathophysiological func-
tions of cathepsins at non-lysosomal sites.
Another important step in the cascade leading to neuronal
cell death is degradation of extracellular matrix proteins by
microglia-derived proteases other that cathepsins. It has been
shown that excitotoxic cell death of murine hippocampal neu-
rons can be prevented by inhibitors of tissue plasminogen acti-
vator (tPA) or by inhibitors of plasmin in vivo. Plasmin is a
potent activator of the matrix metalloproteinases (MMPs).
MMPs are upregulated after excitotoxic challenge and inhibi-
tion of MMPs prevents kainite-induced excitotoxicity in the
rat brain [127].
As research in the ﬁeld of neurodegeneration moves for-
wards, it becomes apparent that an intricate network of signal-
ling pathways and the variety of cell death mechanisms are
involved in neuronal degeneration. Cytosolic, lysosomal and
microglial proteases emerge as key players in the process.
Our growing understanding of the proteolytic mechanisms
mediating necrosis and neurodegeneration holds promise of
facilitating the development of novel neuroprotective agents
in an eﬀort to battle neurodegenerative disorders.
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